Kura Oncology (KURA)
NASDAQ:KURA
Want to see KURA full AI Analyst Report?
Kura Oncology (KURA) Ownership Overview
2.48% Insiders
10.67% Mutual Funds
3.62% Other Institutional Investors
15.27% ETFs
67.97% Public Companies and Individual Investors
The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 29.56% of the company’s stock is owned by Institutional Investors, 2.48% is owned by Insiders, and 67.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 27, 2026 | xxxxxxxxxxxxx | $94820 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $60421 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $54262 | |
Jan 27, 2026 | xxxxxxxxxxxxx | $15338 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $4904007 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,391,682 | Institution | 4.95% | 41,984,480 | |
| 3,957,094 | Institution | 4.46% | 37,829,819 | |
| 3,680,246 | Institution | 4.15% | 35,183,152 | |
| 2,884,998 | Institution | 3.25% | 27,580,581 | |
| 1,014,650 | Insider | 1.14% | 9,700,054 | |
| 977,701 | Institution | 1.10% | 9,346,822 | |
| 887,136 | Institution | 1.00% | 8,481,020 | |
| 675,305 | Institution | 0.76% | 6,455,916 | |
| 552,534 | Institution | 0.62% | 5,282,225 | |
| 521,523 | Institution | 0.59% | 4,985,760 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,680,246 | Institution | 4.15% | 35,183,152 | |
| 977,701 | Institution | 1.10% | 9,346,822 | |
| 887,136 | Institution | 1.00% | 8,481,020 | |
| 552,534 | Institution | 0.62% | 5,282,225 | |
| 521,523 | Institution | 0.59% | 4,985,760 | |
| 465,154 | Institution | 0.52% | 4,446,872 | |
| 285,998 | Institution | 0.32% | 2,734,141 | |
| 261,457 | Institution | 0.29% | 2,499,529 | |
| 249,187 | Institution | 0.28% | 2,382,228 | |
| 245,051 | Institution | 0.28% | 2,342,688 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,742,608 | Institution | 3.09% | 25,478,828 | |
| 2,726,738 | Institution | 3.07% | 22,168,380 | |
| 1,923,568 | Institution | 2.17% | 17,793,004 | |
| 975,506 | Institution | 1.10% | 7,930,864 | |
| 683,912 | Institution | 0.77% | 6,326,186 | |
| 628,200 | Institution | 0.71% | 5,810,850 | |
| 420,840 | Institution | 0.47% | 3,892,770 | |
| 396,829 | Institution | 0.45% | 3,226,220 | |
| 248,695 | Institution | 0.28% | 2,583,941 | |
| 246,117 | Institution | 0.28% | 2,158,446 |
FAQ
Who Owns Kura Oncology (KURA)?
According to the latest TipRanks data, approximately 3.62% of the company's stock is held by institutional investors, 2.48% is held by insiders, and 67.97% is held by retail investors.
What percentage of Kura Oncology (KURA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.62% of Kura Oncology (KURA) stock is held by institutional investors.
What percentage of Kura Oncology (KURA) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.97% of Kura Oncology (KURA) stock is held by retail investors.
Who owns the most shares of Kura Oncology (KURA)?
Vanguard owns the most shares of Kura Oncology (KURA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.